Clinical Trials Directory

Trials / Completed

CompletedNCT03883516

Improving Emergency Management of Status Epilepticus

Improving Emergency Management of Status Epilepticus - a High-fidelity Simulator-based Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In the trial the effectiveness of pre-briefing physicians with the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physician's clinical performances is investigated.

Detailed description

Status epilepticus (SE) is a life-threatening neurological emergency defined as a state of continuous seizure or multiple seizures without full recovery of sensory, motor and/or cognitive function for at least 30 minutes. To achieve high quality management of SE, the American Epilepsy Society published an evidence-based guideline for the treatment of SE, which serves as reference for most national guidelines, but analyses regarding practicability, strict adherence, correct translation into clinical practice, and identification of recommended treatment steps at risk of being modified or missed are lacking. Simulator-based studies offer a platform for the design of standardized clinical scenarios that enable detailed investigations regarding the effect of the implementation and practicability of treatment guidelines. This randomized controlled intervention study performed at the simulation center of the medical intensive care units (ICUs) at the University Hospital Basel is to investigate the effectiveness of pre-briefing physicians with both the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physicians' clinical performances.. Physicians from different medical specialties and with different duration of clinical experience will be enrolled. Participants will be randomly assigned to one of the following three pre-briefing groups: (1) no pre-briefing prior to the simulation training; (2) pre-briefing with the current SE treatment guidelines; (3) pre-briefing with the consolidated "one page" SE treatment guideline.

Conditions

Interventions

TypeNameDescription
OTHERPre-briefing with the current SE treatment guidelinesinstruction of the study participants according to the evidence-based guideline for the treatment of SE published by the American Epilepsy Society prior to the simulation training
OTHERPre-briefing with a consolidated "one page" SE treatment guideinstruction of the study participants with a consolidated "one page" SE treatment guide prior to the simulation training
OTHERNo Pre-briefingno instruction of the study participants prior to the simulation training

Timeline

Start date
2020-12-01
Primary completion
2024-07-15
Completion
2024-07-15
First posted
2019-03-21
Last updated
2025-04-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03883516. Inclusion in this directory is not an endorsement.